Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Diabetes Care at Austrian GPs (DCA09)

This study has been terminated.
Bristol-Myers Squibb
Information provided by:
AstraZeneca Identifier:
First received: September 17, 2009
Last updated: August 16, 2010
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)